Benitec Biopharma (BNTC) Research & Development (2019 - 2025)
Historic Research & Development for Benitec Biopharma (BNTC) over the last 7 years, with Q2 2025 value amounting to $2.9 million.
- Benitec Biopharma's Research & Development fell 1836.56% to $2.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.3 million, marking a year-over-year increase of 1744.51%. This contributed to the annual value of $18.3 million for FY2025, which is 1744.51% up from last year.
- Per Benitec Biopharma's latest filing, its Research & Development stood at $2.9 million for Q2 2025, which was down 1836.56% from $6.5 million recorded in Q1 2025.
- Benitec Biopharma's 5-year Research & Development high stood at $6.5 million for Q1 2025, and its period low was $2.2 million during Q1 2022.
- In the last 5 years, Benitec Biopharma's Research & Development had a median value of $3.2 million in 2022 and averaged $3.5 million.
- Per our database at Business Quant, Benitec Biopharma's Research & Development skyrocketed by 25917.31% in 2021 and then crashed by 2128.35% in 2022.
- Quarter analysis of 5 years shows Benitec Biopharma's Research & Development stood at $3.1 million in 2021, then grew by 19.55% to $3.8 million in 2022, then soared by 35.66% to $5.1 million in 2023, then grew by 5.55% to $5.4 million in 2024, then plummeted by 46.76% to $2.9 million in 2025.
- Its Research & Development was $2.9 million in Q2 2025, compared to $6.5 million in Q1 2025 and $5.4 million in Q4 2024.